Lexology June 2, 2023
Skadden Arps Slate Meagher & Flom LLP

We are pleased to present the first issue of our newsletter analyzing recent trends and developments impacting the life sciences industry, including DOJ policy updates and key provisions of the Food and Drug Omnibus Reform Act.

What Life Sciences Companies Need To Know About Recent Changes to DOJ Policies

In the first quarter of 2023, the Department of Justice (DOJ) announced a series of updates to existing policies, as well as some entirely new policies, relating to the prosecution of corporate crime and the corresponding evaluation of corporate compliance programs.

These DOJ policies apply across industries, but...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Govt Agencies, Pharma / Biotech, Regulations
Health Economics and Outcomes Research: Biopharma’s Underappreciated Value Creator
BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs
Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M
AI Accelerates Discovery of Genes Linked to Neurodevelopmental Disorders
A new era of Made in America drug manufacturing

Share This Article